BPS Announces Call for Subject Matter Experts for Emergency Medicine Role Delineation Study
Washington, DC – The Board of Pharmacy Specialties (BPS) has approved a practice analysis or role delineation study in emergency medicine pharmacy for 2017. Conducting a role delineation study is a critical step in evaluating a proposed specialty. The purpose of the role delineation study is to determine whether this practice area is based upon specialized knowledge of the pharmaceutical sciences, as well as specialized functions routinely performed by practitioners in the proposed specialty. BPS will appoint approximately 15 individuals with expertise in emergency medicine pharmacy to conduct a practice analysis of this proposed specialty.
Individuals wishing to be considered for appointment to the Emergency Medicine Pharmacy Role Delineation Study Taskforce should apply using the link below by 5 pm EST on July 7, 2017. BPS will make appointments by July 21, 2017 and the taskforce will convene in Alexandria, VA on August 26-27, 2017. BPS will cover travel, lodging, meals and miscellaneous expenses for the members of the taskforce to participate in the meeting.
“With over 45 PGY2 residency programs in Emergency Medicine Pharmacy there is clearly strong interest in this practice area. The emergency department setting is complex and one which can benefit from highly qualified pharmacists as integral members of the multidisciplinary care team to help assure optimal pharmaceutical care and patient safety. This role delineation study will explore the areas of pharmacist involvement commonly cited in the literature including but not limited to resuscitation activities, trauma responses, protocol development, formulary optimization, and emergency preparedness as well as the knowledge base required for this practice area, ” noted BPS Executive Director, William M. Ellis.
The initial report of the taskforce will be reviewed by an outside panel of subject matter experts and then validated via a survey administered to pharmacists practicing in the area. If the role delineation study yields information suggesting that emergency medicine pharmacy should be considered as a specialty practice in pharmacy, BPS will then issue a call to the profession for a petition for specialty recognition of emergency medicine pharmacy practice.
ABOUT THE BOARD OF PHARMACY SPECIALTIES®
The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world.
Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels as a result of the rigorous standards mandated by BPS board certification and recertification. Today over 30,000 pharmacists worldwide hold BPS certification.